Shimeng Li
Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhaled exogenous thymosin beta 4 suppresses bleomycin-induced pulmonary fibrosis in mice via TGF-β1 signalling pathway.
Journal: The Journal of pharmacy and pharmacology
Published: June 04, 2024
Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Journal: Biochemical pharmacology
Published: January 04, 2024
Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
Journal: Molecules (Basel, Switzerland)
Published: December 30, 2022
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Journal: BMC pulmonary medicine
Published: September 07, 2022
Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Journal: International immunopharmacology
Published: July 09, 2022
Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization.
Journal: International immunopharmacology
Published: April 18, 2022
Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice.
Journal: International immunopharmacology
Published: August 18, 2021
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice.
Journal: Frontiers in pharmacology
Published: April 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026